Literature DB >> 21845114

Advances in lung transplantation.

V G Valentine1, P M McFadden, J L Ochsner.   

Abstract

Success in lung transplantation (LT) has been attributed to proper patient and donor selection, better preservation and surgical techniques, and experience in postoperative management. In 1995, we refined our perioperative management by implementing newer perioperative strategies with critical pathways and have reduced use of cardio-pulmonary bypass (CPB), thereby improving survival after LT. We compared survival, use of CPB, intubation, intensive care unit (ICU) stay, and hospital times between PRE (prior to 1995) and POST cohorts to analyze our changes in LT. The 1-and 3-year survival rates were 57% and 29% for PRE, and 86% and 62% for POST, p < 0.01. The intubation time and ICU and hospital length of stay were significantly reduced in the POST cohort. Also, the need for CPB was reduced by about 40% in the POST group.

Entities:  

Year:  1999        PMID: 21845114      PMCID: PMC3145423     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  20 in total

1.  A new organ preservation solution, Celsior, is superior to Euro-Collins and University of Wisconsin solutions in decreasing lung reperfusion injury.

Authors:  M L Barr; G P Nishanian; Y Sakamaki; J N Carey; J Chang; V A Starnes
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

2.  Effects of lung preservation with Euro-Collins and University of Wisconsin solutions on endothelium-dependent relaxations.

Authors:  M Strüber; K A Ehlers; F N Nilsson; V M Miller; C G McGregor; A Haverich
Journal:  Ann Thorac Surg       Date:  1997-05       Impact factor: 4.330

Review 3.  Lung transplantation.

Authors:  E P Trulock
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

4.  Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients.

Authors:  M V Soghikian; V G Valentine; G J Berry; H R Patel; R C Robbins; J Theodore
Journal:  J Heart Lung Transplant       Date:  1996-09       Impact factor: 10.247

5.  Predictors, frequency, and indications for cardiopulmonary bypass during lung transplantation in adults.

Authors:  A N Triantafillou; M K Pasque; C B Huddleston; C G Pond; R F Cerza; R M Forstot; J D Cooper; G A Patterson; D G Lappas
Journal:  Ann Thorac Surg       Date:  1994-05       Impact factor: 4.330

6.  Lung transplantation in Louisiana: report of the first twenty lung transplants performed in the state.

Authors:  P M McFadden; J L Ochsner; W B Emory; C H Van Meter; A K Pridjian; G S Young; D E Harmon; F W Smart; H O Ventura; J C Scharfenberg
Journal:  J La State Med Soc       Date:  1995-01

7.  A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

Authors:  S R Duncan; W F Grgurich; A T Iacono; G J Burckart; S A Yousem; I L Paradis; P A Williams; B A Johnson; B P Griffith
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

8.  Selection and evaluation of recipients for heart-lung and lung transplantation.

Authors:  S E Marshall; M R Kramer; N J Lewiston; V A Starnes; J Theodore
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

9.  Lung transplantation after previous thoracic surgical procedures.

Authors:  F C Detterbeck; T M Egan; M R Mill
Journal:  Ann Thorac Surg       Date:  1995-07       Impact factor: 4.330

10.  The development of heart and heart-lung transplantation at Stanford. Honored guest's lecture.

Authors:  N Shumway
Journal:  Eur J Cardiothorac Surg       Date:  1993       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.